Related Experiment Video
Updated: May 3, 2026
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
915
[Lymphohistiocytic activation syndrome (LHAS)]
Annales Francaises D'Anesthesie Et De Reanimation
|January 21, 2014
Summary
Lymphohistiocytic activation syndrome (LHAS) involves overactive immune cells, presenting with fever, enlarged organs, and abnormal blood counts. Early diagnosis is crucial for managing this emergency condition, with genetic studies offering insights into its causes.
Area of Science:
- Hematology
- Immunology
- Genetics
Context:
- Lymphohistiocytic activation syndrome (LHAS) is a critical condition characterized by inappropriate macrophage activation.
- It presents with non-specific clinical signs like fever, hepatosplenomegaly, and lymphadenopathy.
- Associated biological markers include cytopenias, liver dysfunction, coagulopathy, and elevated LDH, ferritin, and triglycerides.
Purpose:
- To define the clinical and biological characteristics of Lymphohistiocytic activation syndrome (LHAS).
- To emphasize the diagnostic urgency of LHAS in febrile cytopenia cases.
- To highlight the importance of understanding the etiology, particularly through genetic studies.
Summary:
- LHAS involves aberrant macrophage stimulation in the bone marrow and lymphoid system.
- Clinical manifestations are diverse, including fever, malaise, organomegaly, and lymphadenopathy.
- Key laboratory findings encompass cytopenias, abnormal liver function, coagulopathy, and elevated inflammatory markers.
Impact:
- Highlights the critical need for prompt diagnosis and management of LHAS.
- Underscores the role of genetic research in elucidating the underlying mechanisms of familial LHAS.
- Aims to improve clinical recognition and timely intervention for patients with febrile cytopenias.
